TABLE 1.
Variable | Median (IQR)/number (%) |
---|---|
Gender (male) | 213 (78.02%) |
Age (years) | 29 (22, 36.5) |
Median course (months) | 12 (7, 36) |
BMI | 19.43 (17.50, 22.06) |
Smoking | |
Current smoker | 15 (5.49%) |
Former smoker | 14 (5.13%) |
Never | 244 (89.38%) |
Drinking | |
Current drinker | 4 (1.47%) |
Former drinker | 5 (1.83%) |
Never | 264 (96.70%) |
Surgery | |
Perianal surgery | 76 (27.84%) |
Intestinal surgery | 30 (10.99%) |
Both | 9 (3.30%) |
Montreal classification | |
Age at diagnosis (years) | |
A1 | 25 (9.16%) |
A2 | 198 (72.53%) |
A3 | 50 (18.32%) |
Disease location | |
L1 | 41 (15.02%) |
L2 | 32 (11.72%) |
L3 | 157 (57.51%) |
L1+4 | 7 (2.56%) |
L2+4 | 1 (0.37%) |
L3+4 | 35 (12.82%) |
Behavior | |
B1 | 153 (56.04%) |
B2 | 91 (33.33%) |
B3 | 22 (8.06%) |
B2+3 | 7 (2.56%) |
p | 114 (41.76%) |
Treatment | |
5-aminosalicylates | 97 (35.53%) |
Corticosteroids | 19 (6.96%) |
Immunomodulators | 29 (10.62%) |
Biologics | 159 (58.24%) |
Bowel resection | 39 (14.29%) |
Clinical activity | |
Remission | 159 (58.24%) |
Mildly active | 58 (21.25%) |
Moderately active | 54 (19.78%) |
Severely active | 2 (0.73%) |
Endoscopic activity | |
Remission | 76 (27.84%) |
Mildly active | 95 (34.80%) |
Moderately active | 82 (30.04%) |
Severely active | 20 (7.33%) |
Abbreviations: CD, Crohn’s disease; IQR, inter-quartile range; BMI, body mass index.